Development of disease-specific growth charts in Turner syndrome and Noonan syndrome
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Many congenital diseases are associated with growth failure, and patients with these diseases have specific growth patterns. As the growth patterns of affected individuals differ from those of normal populations, it is challenging to detect additional conditions that can influence growth using standard growth charts. Disease-specific growth charts are thus very useful tools and can be helpful for understanding the growth pattern and pathogenesis of congenital diseases. In addition, disease-specific growth charts allow doctors to detect deviations from the usual growth patterns for early diagnosis of an additional condition and can be used to evaluate the effects of growth-promoting treatment for patients. When developing these charts, factors that can affect the reliability of the charts should be considered. These factors include the definition of the disease with growth failure, selection bias in the measurements used to develop the charts, secular trends of the subjects, the numbers of subjects of varying ages and ethnicities, and the statistical method used to develop the charts. In this review, we summarize the development of disease-specific growth charts for Japanese individuals with Turner syndrome and Noonan syndrome and evaluate the efforts to collect unbiased measurements of subjects with these diseases. These charts were the only available disease-specific growth charts of Turner syndrome and Noonan syndrome for Asian populations and were developed using a Japanese population. Therefore, when these charts are adopted for Asian populations other than Japanese, different growth patterns should be considered.
Abstract
Many congenital diseases are associated with growth failure, and patients with these diseases have specific growth patterns. As the growth patterns of affected individuals differ from those of normal populations, it is challenging to detect additional conditions that can influence growth using standard growth charts. Disease-specific growth charts are thus very useful tools and can be helpful for understanding the growth pattern and pathogenesis of congenital diseases. In addition, disease-specific growth charts allow doctors to detect deviations from the usual growth patterns for early diagnosis of an additional condition and can be used to evaluate the effects of growth-promoting treatment for patients. When developing these charts, factors that can affect the reliability of the charts should be considered. These factors include the definition of the disease with growth failure, selection bias in the measurements used to develop the charts, secular trends of the subjects, the numbers of subjects of varying ages and ethnicities, and the statistical method used to develop the charts. In this review, we summarize the development of disease-specific growth charts for Japanese individuals with Turner syndrome and Noonan syndrome and evaluate the efforts to collect unbiased measurements of subjects with these diseases. These charts were the only available disease-specific growth charts of Turner syndrome and Noonan syndrome for Asian populations and were developed using a Japanese population. Therefore, when these charts are adopted for Asian populations other than Japanese, different growth patterns should be considered.
참고문헌 (47)
- Hermanussen M, "Auxology: an update", Horm Res Paediatr, 74, pp.153~164 (2010)
- de Onis M, "Worldwide practices in child growth monitoring", J Pediatr, 144, pp.461~465 (2004)
- Ranke MB, "Disease-specific standards in congenital syndromes", Horm Res, 45(Suppl 2), pp.35~41 (1996)
- Nagai T, "Standard growth curves for Japanese patients with Prader-Willi syndrome", Am J Med Genet, 95, pp.130~134 (2000)
- Styles ME, "New cross sectional stature, weight, and head circumference references for Down's syndrome in the UK and Republic of Ireland", Arch Dis Child, 87, pp.104~108 (2002)
- Martin ND, "New height, weight and head circumference charts for British children with Williams syndrome", Arch Dis Child, 92, pp.598~601 (2007)
- Isojima T, "New reference growth charts for Japanese girls with Turner syndrome", Pediatr Int, 51, pp.709~714 (2009)
- Isojima T, "Proposal of new auxological standards for Japanese girls with turner syndrome", Clin Pediatr Endocrinol, 19, pp.69~82 (2010)
- Isojima T, "Growth references for Japanese individuals with Noonan syndrome", Pediatr Res, 79, pp.543~548 (2016)
- Isojima T, "Validation of auxological reference values for Japanese children with Noonan syndrome and comparison with growth in children with Turner syndrome", Clin Pediatr Endocrinol, 26, pp.153~164 (2017)
- Saenger P, "Turner's syndrome", N Engl J Med, 335, pp.1749~1754 (1996)
- Ranke MB, "Turner's syndrome", Lancet, 358, pp.309~314 (2001)
- Sybert VP, "Turner's syndrome", N Engl J Med, 351, pp.1227~1238 (2004)
- Ranke MB, "Adult height in Turner syndrome: results of a multinational survey 1993", Horm Res, 42, pp.90~94 (1994)
- Lyon AJ, "Growth curve for girls with Turner syndrome", Arch Dis Child, 60, pp.932~935 (1985)
- Rongen-Westerlaken C, "Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment", Acta Paediatr, 86, pp.937~942 (1997)
- Haeusler G, "Spontaneous growth in Turner syndrome: evidence for a minor pubertal growth spurt", Eur J Pediatr, 151, pp.283~287 (1992)
- Bertapelli F, "Growth curves for girls with Turner syndrome", Biomed Res Int, 2014, pp.687978~ (2014)
- Darendeliler F, "Growth curves for Turkish Girls with Turner Syndrome: Results of the Turkish Turner Syndrome Study Group", J Clin Res Pediatr Endocrinol, 7, pp.183~191 (2015)
- Suwa S, "Standards for growth and growth velocity in Turner's syndrome", Acta Paediatr Jpn, 34, pp.206~220 (1992)
- Naeraa RW, "Standards for growth and final height in Turner's syndrome", Acta Paediatr Scand, 79, pp.182~190 (1990)
- Massa G, "Linear growth in patients with Turner syndrome: influence of spontaneous puberty and parental height", Eur J Pediatr, 149, pp.246~250 (1990)
- Ranke MB, "Turner syndrome: spontaneous growth in 150 cases and review of the literature", Eur J Pediatr, 141, pp.81~88 (1983)
- Tanaka T, "Registration system for growth hormone (GH) treatment with standardized immunoreactive GH values in Japan", Endocr J, 45, pp.459~465 (1998)
- Isojima T, "Trends in age and anthropometric data at start of growth hormone treatment for girls with Turner syndrome in Japan", Endocr J, 55, pp.1065~1070 (2008)
- Mochizuki T, "A questionnaire survey of the follow-up status in adult Turner women in Japan", Jpn J Pediatr, 114, pp.43~47 (2010)
- Romano AA, "Noonan syndrome: clinical features, diagnosis, and management guidelines", Pediatrics, 126, pp.746~759 (2010)
- Nora JJ, "The Ullrich-Noonan syndrome (Turner phenotype)", Am J Dis Child, 127, pp.48~55 (1974)
- Mendez HM, "Noonan syndrome: a review", Am J Med Genet, 21, pp.493~506 (1985)
- Noonan JA, "Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease", Am J Dis Child, 116, pp.373~380 (1968)
- Allanson JE, "Noonan syndrome: the changing phenotype", Am J Med Genet, 21, pp.507~514 (1985)
- Tartaglia M, "Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome", Nat Genet, 29, pp.465~468 (2001)
- Aoki Y, "Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS", MAPK pathway syndrome, 2013, pp.93, 173~180
- Tartaglia M, "Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms", Ann N Y Acad Sci, 1214, pp.99~121 (2010)
- Tartaglia M, "Noonan syndrome: clinical aspects and molecular pathogenesis", Mol Syndromol, 1, pp.2~26 (2010)
- van der Burgt I, "Noonan syndrome", Orphanet J Rare Dis, 2, pp.4~ (2007)
- van der Burgt I, "Clinical and molecular studies in a large Dutch family with Noonan syndrome", Am J Med Genet, 53, pp.187~191 (1994)
- Ranke MB, "Noonan syndrome: growth and clinical manifestations in 144 cases", Eur J Pediatr, 148, pp.220~227 (1988)
- Witt DR, "Growth curves for height in Noonan syndrome", Clin Genet, 30, pp.150~153 (1986)
- Malaquias AC, "Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS", MAPK pathway, 2012, pp.158A, 2700~2706
- Otten BJ, "Growth in Noonan syndrome", Horm Res, 72(Suppl 2), pp.31~35 (2009)
- Noonan JA, "Adult height in Noonan syndrome", Am J Med Genet A, 123A, pp.68~71 (2003)
- Cole TJ, "Smoothing reference centile curves: the LMS method and penalized likelihood", Stat Med, 11, pp.1305~1319 (1992)
- Wright EM, "A comparison of statistical methods for age-related reference intervals", J Royal Stat Soc A, 160, pp.47~69 (1997)
- Cole TJ, "Fitting smoothed centile curves to reference data", J Royal Stat Soc A, 151, pp.385~418 (1988)
- Isojima T, "Growth standard charts for Japanese children with mean and standard deviation (SD) values based on the year 2000 national survey", Clin Pediatr Endocrinol, 25, pp.71~76 (2016)
- 문진수, "2007 한국 소아 청소년 성장도표 : 개발 과정과 전망", Korean Journal of Pediatrics, 51(1), pp.1~25 (2008), 대한소아과학회